Skip to content

Study on the validation of the California Verbal Learning Test- 2nd Edition- Japanese version

Study on the validation of the California Verbal Learning Test- 2nd Edition- Japanese version - Validity of the California Verbal Learning Test- 2nd Edition- Japanese version

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000013623
Enrollment
60
Registered
2014-05-03
Start date
2014-05-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar disorder

Interventions

None listed

Sponsors

National Center of Neurology and Psychiatry
Lead Sponsor
Hokkaido University Nagoya University Fujita Health University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A. Patients (1) Meeting DSM-V criteria for bipolar disorder (type I or II) (2) Outpatients (3)20 or older and younger than 60 in age (4)remitted at the time of assessment, i.e. 7 points or less with the Montgomery-Asberg Depression Rating Scale, and 8 points or less with the Young Mania Rating Scale (5) Having a family member or caregiver capable of assessing social/functional outcome of the subject (6) Capable of understanding the purpose and content of the study, and providing informed consent to participate B. Healthy subjects (1) Not meeting any of the DSM-V criteria (2) 20 or older and younger than 60 in age (3)Capable of understanding the purpose and content of the study, and providing informed consent to participate

Exclusion criteria

Exclusion criteria: A. Patients (1) Past or present history of severe organic brain lesions or injury (with conciousness loss lasting 10 minutes or longer) (2) Comorbidity of alcohol or substance use (excluding caffeine and nicotine) witnin 12 months (3)Meeting DSM-V criteria for personality disorder or mental retardation (4) Not eligible due to other reasons as judged by investigators B. Healthy subjects Same as in patients

Design outcomes

Primary

MeasureTime frame
CVLT-II BACS-J(Brief Assessment of Cognitive function in Schizophrenia Japanese version UPSA-B (International version) SLOF(Specific Levels of Functioning Assessment)

Countries

Japan

Contacts

Public ContactKazuki Sueyoshi

National Center of Neurology and Psychiatry Department of Clinical Epidemiology

sueyosi@ncnp.go.jp042-341-2711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026